Sygnature Discovery
Sygnature Discovery Overview
Sygnature Discovery is a world-leading integrated drug discovery contract research organization based in the UK and Canada, known for delivering innovative solutions across a variety of therapeutic areas and achieving significant results since 2011.
Key Findings
Industries
- •Pharmaceuticals
- •Biotechnology
- •Contract Research Organization
Featured Products
- •Integrated Drug Discovery
- •Target Identification
- •Target Validation
- •Hit Identification
- •Hit-to-Lead
- •Lead Optimisation
- •Fragment Based Drug Discovery
- •Structure-Based Drug Discovery
- •Route of Administration
- •Targeted Protein Degradation
- •Antibody Drug Conjugates
- •Ion Channel Screening
- •Cell Line Generation
- •Assay Development
- •Screening
- •Cell Based Assays
- •Biochemical Assays
- •Biophysical Characterisation
- •Biomarker Discovery
- •Primary Tissues
- •Medicinal Chemistry
- •Synthetic Chemistry
- •Analytical Chemistry
- •High Throughput Chemistry
- •Process Chemistry
- •Artificial Intelligence (AI)
- •Dotmatics Support
- •Target Analysis
- •Virtual Screening
- •Structure Based Drug Design
- •Ligand-Based Drug Design
- •Compound Library Design
- •ADMET Prediction Software
- •Computer Science and Informatics
- •In Vitro ADME & Physicochemical Profiling
- •Metabolite Identification & Method Development
- •In Vivo Pharmacokinetics & Bioanalysis
- •Modelling and Simulation
- •DMPK Consultancy
- •CNS Disorder Models
- •CNS Safety
- •Fibrosis and Inflammation Models
- •Metabolic Models
- •Oncology Models
- •Early Clinical Formulation
- •Solid Form Analysis
- •Salt and Co-crystal Screening
- •Polymorph Screening
- •CMC Activities
- •Pre-Clinical Formulation
Keywords
- •drug discovery
- •biotech
- •pharma
- •CRO
- •integrated drug discovery
- •contract research organization
- •clinical trials